Schedule 13G ownership disclosure
HERON THERAPEUTICS, INC.
Common Stock, par value $0.01 per share · CUSIP: 427746102
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Clearline Capital LP
Shares: 12,235,239.00 · Class: 6.7%
- Clearline Capital LLC
Shares: 12,235,239.00 · Class: 6.7%
- Marc Majzner
Shares: 12,235,239.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001600136-26-000002
- Form type
- SCHEDULE 13G/A
- Filer
- Clearline Capital LP
- CIK
- CIK 1600136
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership